Skip to main content

Table 3 Summary of grade 3–4 toxicities

From: Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)

Toxicity

Grade 3

Grade 4

Total

Liver Function Adverse Events

Bilirubin (N = 58)

7

1

8

Albumin (N = 58)

1

0

1

AST (N = 58)

1

1

2

ALT (N = 58)

2

1

3

INR (N = 48)

0

0

0

Other Laboratory Adverse Events

Thrombocytopenia

3

0

3

Leukopenia

1

0

1

Constitutional Adverse events

Fever

1

0

1

Abdominal Pain

1

0

1

Flank Pain

1

0

1

Abdominal Distention

1

0

1

Nausea

1

0

1

Non-cardiac chest pain

1

0

1

Stomach Pain

1

0

1

Tumor lysis Syndrome

1

0

1

Urinary tract infection

1

0

1

Total:

24

3

27

  1. AST aspartate aminotransferase, ALT alanine aminotransferase, INR international normalized ratio